Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE

Summary

The investigators propose a study to evaluate the safety, local tolerability, convenience, and efficacy of self-administered Icatibant for the treatment of acute attacks of hereditary angioedema. The investigators believe that self administration with Icatibant for treatment of an acute attack of angioedema will not change the time to complete or near complete resolution of symptoms compared to treatment with Icatibant in a medical facility.

Timeline

Start

2011-12

Primary completion

2014-04

Completion

2014-04

Drugs

Indications